Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nevena Kalicanin"'
Autor:
Zorana Ferjancic, Filip Bihelovic, Bojan Vulovic, Radomir Matovic, Milena Trmcic, Aleksandar Jankovic, Milos Pavlovic, Filip Djurkovic, Radivoje Prodanovic, Aleksandra Djurdjevic Djelmas, Nevena Kalicanin, Mario Zlatovic, Dusan Sladic, Thomas Vallet, Marco Vignuzzi, Radomir N. Saicic
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 39, Iss 1 (2024)
AbstractWe developed new iminosugar-based glycosidase inhibitors against SARS-CoV-2. Known drugs (miglustat, migalastat, miglitol, and swainsonine) were chosen as lead compounds to develop three classes of glycosidase inhibitors (α-glucosidase, α-g
Externí odkaz:
https://doaj.org/article/42b63272ecfc453f83c5a84edc1ae71b
Autor:
Zorana Ferjancic, Filip Bihelovic, Bojan Vulovic, Radomir Matovic, Milena Trmcic, Aleksandar Jankovic, Milos Pavlovic, Filip Djurkovic, Radivoje Prodanovic, Aleksandra Djurdjevic Djelmas, Nevena Kalicanin, Mario Zlatovic, Dusan Sladic, Thomas Vallet, Marco Vignuzzi, Radomir N. Saicic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f444cf98048a9518f9004ee82ce9c911
https://doi.org/10.2139/ssrn.4423287
https://doi.org/10.2139/ssrn.4423287
Autor:
Sara Protić, Nevena Kaličanin, Milan Sencanski, Olivera Prodanović, Jelena Milicevic, Vladimir Perovic, Slobodan Paessler, Radivoje Prodanović, Sanja Glisic
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 3, p 1955 (2023)
Finding an effective drug to prevent or treat COVID-19 is of utmost importance in tcurrent pandemic. Since developing a new treatment takes a significant amount of time, drug repurposing can be an effective option for achieving a rapid response. This
Externí odkaz:
https://doaj.org/article/f71856b854ad4c3fb905a17a91ab95a8
Autor:
Ivana Đukić, Nevena Kaličanin, Milan Sencanski, Snezana B. Pajovic, Jelena Milicevic, Jelena Prljic, Slobodan Paessler, Radivoje Prodanović, Sanja Glisic
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 28, Iss 1, p 8 (2023)
Background: Drug resistance is a critical problem in health care that affects therapy outcomes and requires new approaches to drug design. SARS-CoV-2 Mpro mutations are of concern as they can potentially reduce therapeutic efficacy. Viral infections
Externí odkaz:
https://doaj.org/article/bf2eb6013eb24f28b6e4b60f0def1ec7